Prevalence of Viral Markers in Sera of Blood Donors and Hemophilic Patients Treated With Different Concentrates
| Group . | . | No. . | TTV-DNA . | No. (% of total) of Serum Samples Positive for Virus Markers . | |||
|---|---|---|---|---|---|---|---|
| HBsAg . | HCV-RNA . | HGV-RNA . | Anti-HIV . | ||||
| Healthy blood donors | A | 100 | 22 (22%), PAvB < .0001 | 0 (0%) | 0 (0%), PAvB < .0001 | 2 (2%) | 0 (0%), PAvB < .0001 |
| Hemophilic patients | B | 178 | 123 (69%) | 6 (3%) | 113 (63%) | 11 (6%) | 30 (17%) |
| Type of factor infused | |||||||
| Nonvirus-inactivated | C | 127 | 99 (78%), PCvE < .0001 | 6 (5%) | 108 (85%), PCvE < .0001 | 10 (8%) | 30 (24%), PCvE < .0001 |
| Virus-inactivated | D | 33 | 22 (67%), PDvE < .001 | 0 (0%) | 5 (15%) | 1 (3%) | 0 (0%) |
| Recombinant | E | 18 | 2 (11%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
| Group . | . | No. . | TTV-DNA . | No. (% of total) of Serum Samples Positive for Virus Markers . | |||
|---|---|---|---|---|---|---|---|
| HBsAg . | HCV-RNA . | HGV-RNA . | Anti-HIV . | ||||
| Healthy blood donors | A | 100 | 22 (22%), PAvB < .0001 | 0 (0%) | 0 (0%), PAvB < .0001 | 2 (2%) | 0 (0%), PAvB < .0001 |
| Hemophilic patients | B | 178 | 123 (69%) | 6 (3%) | 113 (63%) | 11 (6%) | 30 (17%) |
| Type of factor infused | |||||||
| Nonvirus-inactivated | C | 127 | 99 (78%), PCvE < .0001 | 6 (5%) | 108 (85%), PCvE < .0001 | 10 (8%) | 30 (24%), PCvE < .0001 |
| Virus-inactivated | D | 33 | 22 (67%), PDvE < .001 | 0 (0%) | 5 (15%) | 1 (3%) | 0 (0%) |
| Recombinant | E | 18 | 2 (11%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |